Induction of apoptosis by Paljin-Hangahmdan on human leukemia cells

Journal of Ethnopharmacology

Volumn 88, Issue 1, 2003, Pages 79-83

  Yi, Jin Mu ^a,c   Kim, Mi Sun ^a   Lee, Eun Hee ^a   Wi, Dae Han ^b   Lee, Jai Kyoo ^b   Cho, Kwang Ho ^b   Hong, Seung Heon ^c   Kim, Hyung Min ^a  

^a Kyung Hee University   (South Korea)

^b Wonkwang University School of Medicine   (South Korea)

^c Wonkwang University   (South Korea)

Author keywords

Apoptosis; Cancer; Human leukemia cells; Paljin Hangahmdan

Indexed keywords

DNA FRAGMENT; PALJIN HANGAHMDAN EXTRACT; PLANT EXTRACT; UNCLASSIFIED DRUG;

AGAR GEL ELECTROPHORESIS; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL CYCLE; COLORIMETRY; CONTROLLED STUDY; CYTOTOXICITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LEUKEMIA CELL; MEDICINAL PLANT; MICROSCOPY; PALJIN HANGAHMDAN; PROMYELOCYTIC LEUKEMIA;

EID: 0042167357     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-8741(03)00177-6     Document Type: Article

References (21)

1. Arcamone, F., 1981. Doxorubicin. Anticancer Antibiotics, Academic Press, New York.
2. Bold R.J., Termuhlen P.M., McConkey D.J. Apoptosis, cancer and cancer therapy. Surgical Oncology - Oxford. 6:1997;133-142.
3. Brown J.M., Wouters B.G. Apoptosis, p53, and tumour cell sensitivity to anticancer agents. Cancer Research. 59:1999;1391-1399.
4. Burden D.A., Osheroff N. Mechanism of action of topoisomerase II and drugs targeted to the enzyme. Biochimica et Biophysica Acta. 1400:1998;139-154.
5. Buttke T.M., Sandstrom P.A. Oxidative stress as a mediator of apoptosis. Immunology Today. 15:1994;7-10.
6. Fisher D.E. Apoptosis in cancer therapy: crossing the threshold. Cell. 78:1994;539-542.
7. Kamesaki H. Mechanism involved in chemotherapy-induced apoptosis and their implications in cancer chemotherapy. International Journal of Hematology. 68:1998;29-43.
8. Kaufman S.H. Cell death induced by topoisomerase-targeted drugs: more questions than answers. Biochimica et Biophysica Acta. 1400:1998;195-211.
9. Kaufmann S.H., Earnshaw W.C. Induction of apoptosis by cancer chemotherapy. Experimental Cell Research. 256:2000;42-49.
10. Loo D.T., Rillema J.R. Measurement of cell death. Methods In Cell Biology. 57:1998;251-264.
11. Lowe S.W., Lin A.W. Apoptosis in cancer. Carcinogenesis. 21:2000;485-495.
12. McConkey D.J., Zhivotovsky B., Orrenius S. Apoptosismolecular mechanisms and biomedical implications. Molecular Aspects of Medicine. 17:1996;1-110.
13. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. Journal of Immunological Methods. 65:1983;55-63.
14. Panchal R.G. Novel therapeutic strategies to selectively kill cancer cells. Biochemical Pharmacology. 55:1998;247-252.
15. Singal P.K., Iliskovic N. Doxorubicin-induced cardiomyopathy. New England Journal of Medicine. 339:1998;900-905.
16. Smets L.A. Programmed cell death (apoptosis) and response to anti-cancer drugs. Anticancer Drugs. 5:1994;3-9.
17. Watson A.J. Review article: manipulation of cell death - the development of novel strategies for the treatment of gastrointestinal disease. Alimentary Pharmacology and Therapeutics. 9:1995;215-226.
18. Weiss R.B. The anthracyclines: will we ever find a better doxorubicine. Seminars in Oncology. 19:1992;670-686.
19. Woynarowska B.A., Woynarowski J.M. Preferential targeting of apoptosis in tumor versus normal cells. Biochimica et Biophysica Acta. 1587:2002;309-317.
20. Wyllie A.H. The biology of cell death in tumours. Anticancer Research. 5:1985;131-142.
21. Yang L.L., Lee C.Y., Yen K.Y. Induction of apoptosis by hydrolysable tannins from Eugenia jambos L. on human leukemia cells. Cancer letters. 157:2000;65-75.